LATEST YOUTUBE VIDEO :
iFabric Corp, through its U.S. subsidiary Intelligent Fabric Technologies (North America) Inc., has announced a massive expansion of its "Doctor’s Choice" medical scrubs program. The performance-enhanced apparel will now be available in 1,000 additional stores of a leading U.S. national big-box retailer. This move signals a growing consumer and institutional demand for "smart textiles" that offer more than just basic coverage.
The scrubs utilize proprietary technologies like PROTX2, an advanced antimicrobial finish, and ecoPEL, a PFAS-free water repellent. These technologies are integrated into the fabric at the molecular level, allowing the garments to maintain their protective properties even after multiple industrial washings. The expansion follows a successful pilot program in late 2025 that demonstrated strong sell-through rates among healthcare professionals.
A key driver for this expansion was the recent publication of peer-reviewed clinical trial results. The study showed that scrubs treated with iFabric's technologies had significantly lower levels of bacterial contamination compared to standard untreated scrubs in real-world hospital environments. This clinical validation has become a major selling point in a market where "performance claims" are often met with skepticism by savvy medical buyers.
The move also highlights a shift in the U.S. retail landscape, where specialized medical apparel is moving from niche catalogs into mainstream retail aisles. As the U.S. population ages and the healthcare workforce grows, the demand for durable, high-performance workwear is skyrocketing. iFabric's ability to combine comfort, durability, and clinical safety has positioned it at the forefront of this "medical-retail" convergence.
The company plans to further leverage this retail footprint by introducing additional tech-enabled products, such as antimicrobial undergarments and moisture-managing activewear. By securing 1,000 physical store locations, iFabric has solved one of the biggest hurdles for textile tech companies: physical accessibility. The expansion is expected to significantly boost the company's 2026 revenue and solidify its partnership with major U.S. retail giants.
iFabric's "Doctor’s Choice" scrubs expanded into 1,000 additional U.S. big-box retail locations.
The apparel features PROTX2 antimicrobial and ecoPEL water-repellent technologies.
Peer-reviewed clinical trials recently validated the scrubs' ability to reduce bacterial contamination.
The expansion follows a successful 2025 pilot program and high healthcare worker demand.
iFabric is moving performance medical textiles from niche markets into mainstream retail.
HISTORY The market for medical textiles saw a dramatic surge in 2024 and 2025 as the industry moved beyond the initial "mask-and-gown" rush of the pandemic era. Manufacturers began focusing on long-term "biosafety" features for everyday uniforms. This period was also characterized by a crackdown on "PFAS" (forever chemicals), forcing companies like iFabric to innovate with eco-friendly alternatives like ecoPEL.
In 2024, California passed legislation banning PFAS in all new apparel, sparking a nationwide shift in textile finishing.
2025 saw a record number of textile-related patent filings for "smart" antimicrobial and self-cleaning fabrics.
The initial rollout of "Doctor's Choice" began as an online-only exclusive in mid-2025 before moving to physical stores.
Throughout 2025, healthcare worker unions began advocating for "clinically-validated" protective gear for their members.
The "Intelligent Fabric" sector grew by an estimated 12% in 2025, outperforming the general apparel market.